Methoxetamine (MXE)

Description

Methoxetamine (MXE): Premium Dissociative for Receptor Research

Methoxetamine (MXE) is a dissociative arylcyclohexylamine compound used in NMDA receptor studies, psychopharmacology, and behavioral neuroscience research. Structurally related to ketamine and PCP analogs, MXE offers a longer-lasting and more selective receptor profile, making it valuable for analytical and in vitro investigations into glutamate receptor modulation and dissociative states.

Available as a high-purity crystalline powder, MXE is suitable for use in toxicological screenings, neurochemical modeling, and receptor response testing. It is strictly for scientific, forensic, or analytical use only, and not approved for human consumption.

Consistent Purity for High-Precision Results

Our Methoxetamine is synthesized and packaged under strict lab conditions and includes a Certificate of Analysis (COA) with every purchase. With a purity rating of ≥99%, it is trusted by laboratories and institutions conducting research on NMDA antagonists and novel dissociative mechanisms.

• ≥99% lab-verified purity

• Available in quantities from 250mg to 10g

• Sealed in air-tight, contamination-resistant containers

• Compliant with research chemical handling standards

MXE is ideal for studies comparing glutamatergic compounds and their neurobiological impact.

A Preferred Compound in Dissociative Research

MXE is often referenced in academic papers as an alternative to ketamine for its reduced neurotoxicity profile and extended activity window. This makes it a reliable compound for long-term analysis of NMDA antagonism, behavioral effects in lab models, and structure-activity relationship (SAR) assessments.

Its ability to trigger non-competitive inhibition of NMDA receptors makes it valuable in psychiatric and neurological research environments